All times are listed in CEST (Central European Summer Time)

Displaying One Session

Industry Satellite Symposium

F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions

Date
14.09.2020
Chairs
  • Arndt Vogel (Hannover, Germany)
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Welcome and introductions (ID 5321)

Speakers
  • Arndt Vogel (Hannover, Germany)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Tracking the recent advances within the field of unresectable HCC (ID 5322)

Speakers
  • David J. Pinato (London, United Kingdom)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Reviewing the latest phase III efficacy data for unresectable HCC (ID 5323)

Speakers
  • Andrew X. Zhu (Boston, United States of America)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Exploring key safety data for cancer immunotherapy combinations (ID 5325)

Speakers
  • Philippe Merle (Lyon, CEDEX 4, France)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Moving into the clinic: how will these data inform our clinical decisions? (ID 5327)

Speakers
  • Arndt Vogel (Hannover, Germany)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Panel discussion (ID 5329)

Speakers
  • Arndt Vogel (Hannover, Germany)
  • David J. Pinato (London, United Kingdom)
  • Andrew X. Zhu (Boston, United States of America)
  • Philippe Merle (Lyon, CEDEX 4, France)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions Industry Satellite Symposium

Live Q&A - 24 September 2020 - 17:30-18:00 (ID 5522)

Speakers
  • Arndt Vogel (Hannover, Germany)
Session Name
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions